Russell Kerry Strong 4
4 · Terns Pharmaceuticals, Inc. · Filed Jul 6, 2022
Insider Transaction Report
Form 4
Russell Kerry Strong
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-07-01+240,000→ 240,000 totalExercise: $2.69Exp: 2032-06-30→ Common Stock (240,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from May 31, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.